Items Tagged ‘clinical trial’

January 15, 2018

Lynparza Slows Spread of Inherited Breast Cancer Caused by BRCA Mutations: First Drug Approved for BRCA Breast Cancer

By

CancerConnect News: The US Food and Drug Administration (FDA) has extended the approval of Lynparza (olaparib) to include the treatment of metastatic breast cancer in patients who carry the specific inherited BRCA mutation.  These patients can be identified by using the FDA-approved genetic test, BRACAnalysis CDx (Myriad Genetic Laboratories). About BRCA Breast Cancer Breast cancer […]

View full entry

Tags: brca, Breast Cancer, clinical trial, lynparza, News, olaparib, OlympiAD, PARP Inhibitors


December 27, 2017

Long Term Follow Up Shows Durability of Jakafi® Response in Patients with Polycythemia Vera

By

CancerConnect News: Jakafi® (ruxolitinib) was initially reported to help patients with polycythemia vera (PV) maintain hematocrit control more effectively than the best available therapy at the 56th American Hematology Society Annual Meeting in 2014.1,2 Now with a full 4 years of follow-up from this trial the benefit of Jakafi® continues to be confirmed. Results recently presented […]

View full entry

Tags: clinical trial, Incyte, jakafi, Myeloproliferative Neoplasms MPN, News, polycythemia vera, PV, RESPONSE, ruxolitinib


March 9, 2016

Shorter Radiation Schedule Effective in Low-Risk Prostate Cancer

By

Men with low-grade prostate cancer have the same long-term outcomes when they are treated with a shorter radiation schedule, compared to those treated with a longer, conventional radiation schedule. These results were recently presented at the 2016 annual Genitourinary Cancers Symposium. Low-grade prostate cancer refers to cancer that has not spread to distant sites in […]

View full entry

Tags: clinical trial, hypofractionated, Prostate Cancer, radiation


September 21, 2015

Varubi Approved for Chemotherapy-Induced Nausea and Vomiting

By

The United States Food and Drug Administration (FDA) approved the agent Varubi (rolapitant) to be used to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Chemotherapy-induced nausea and vomiting (CINV) is a common side effect of treatment with chemotherapy among cancer patients. It can become a serious side effect in that it can cause dehydration, electrolyte […]

View full entry

Tags: chemotherapy-induced, CINV, clinical trial, nausea, Other News Topics (not Types of Cancer), rolapitant, Varubi, vomiting